Market revenue in 2023 | USD 11,361.6 million |
Market revenue in 2030 | USD 18,788.3 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Cancer surgery |
Fastest growing segment | Chemotherapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy, Bone Marrow Transplantation, Immunotherapy |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer treatment facilities market will help companies and investors design strategic landscapes.
Cancer surgery was the largest segment with a revenue share of 34.12% in 2023. Horizon Databook has segmented the U.S. cancer treatment facilities market based on cancer surgery, chemotherapy, radiation therapy, hormone therapy, bone marrow transplantation, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cancer treatment facilities market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cancer treatment facilities market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account